Ligand Pharmaceuticals
LGNDInsider trades and stock quote 2022-2024
All insider trades at Ligand Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/5/2024 | Sell | Sabba, Stephen L. | Director | $74.3 | $140,650 |
| 2/28/2024 | Sell | Espinoza, Octavio | Chief Financial Officer | $88.5 | $12,384 |
| 9/22/2023 | Buy | Davis, Todd C. | CHIEF EXECUTIVE OFFICER | $59.4 | $237,529 |
| 5/16/2023 | Sell | Kozarich, John W. | Director | $77.2 | $343,081 |
| 5/10/2023 | Sell | Sabba, Stephen L. | Director | $77.1 | $494,225 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)